Hearing aid use linked to better cognition in hearing-impaired elderly

  • A study of older adults with impaired hearing supports the use of hearing aids to help fight the development of cognitive decline and dementia.

A study involving 100 older adults (aged 80-99) with hearing loss has found that those who used a hearing aid performed significantly better on a cognitive test (MMSE) than those who didn't use a hearing aid, despite having poorer hearing. Among non-users, participants with more hearing loss had lower MMSE scores than those with better hearing.

In the MMSE, participants give vocal responses to verbal commands. Executive function was also assessed with the Trail Making Test, Part B, which doesn't have a verbal or auditory component. On this test, although hearing aid users performed better than non-users, the difference was not statistically significant. Nor were scores correlated with hearing level.

The finding suggests that hearing loss is associated with sensory-specific cognitive decline rather than global cognitive impairment.

Of the 100 participants, 34 regularly used a hearing aid.

Previous studies have found hearing loss is associated with greater cognitive decline in older adults. A physician recently told the annual meeting of the American Association for the Advancement of Science (AAAS) that as much as 36% of dementia risk might be attributable to hearing impairment, and urged that doctors treat age-related hearing impairment more seriously.

The finding supports the view that use of hearing aids for the hearing impaired may help keep them more socially engaged, thus preventing or slowing the progression of cognitive decline and the development of dementia.

More than half of adults over age 75 have hearing loss, yet less than 15% of the hearing impaired use a hearing aid.

http://www.eurekalert.org/pub_releases/2016-04/cumc-hau042216.php

Reference: 

Related News

It’s been suggested before that Down syndrome and Alzheimer's are connected. Similarly, there has been evidence for connections between diabetes and Alzheimer’s, and cardiovascular disease and Alzheimer’s. Now new evidence shows that all of these share a common disease mechanism.

Part of the Women's Health Initiative study looking at the effect of hormone therapy on thinking and memory in postmenopausal women, involving over 1400 women, has found those who had high blood pressure at the start of the study (eight years earlier) had significantly higher amounts of

A three-year study involving 169 people with mild cognitive impairment has found that those who later developed Alzheimer's disease showed 10-30% greater atrophy in two specific locations within the

A study involving 511 older adults (average age 78) has found that 11.6% of those with very mild or mild Alzheimer’s (43% of the participants) had mental lapses, compared to only 2 of the 295 without Alzheimer’s. Those with mental lapses also tended to have more severe Alzheimer’s.

Loss of memory and problems with judgment in dementia patients can cause difficulties in relation to eating and nutrition; these problems in turn can lead to poor quality of life, pressure ulcers and infections.

A European trial involving 225 patients with mild Alzheimer's has found that those who drank Souvenaid (a cocktail of uridine, choline and the omega-3 fatty acid DHA, plus B vitamins, phosopholipids and antioxidants) for 12 weeks were more likely to improve their performance in a delayed verbal

Subjective cognitive impairment (SCI), marked by situations such as when a person recognizes they can't remember a name like they used to or where they recently placed important objects the way they used to, is experienced by between one-quarter and one-half of the population over the age of 65.

A German study involving nearly 4000 older adults (55+) has found that physical activity significantly reduced the risk of developing mild cognitive impairment over a two-year period.

Rodent studies have demonstrated the existence of specialized neurons involved in spatial memory.

Although HIV doesn't directly infect neurons, it appears that once it has crossed the blood-brain barrier, it affects supporting cells that can release immune factors that harm neurons.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news
Error | About memory

Error

The website encountered an unexpected error. Please try again later.